-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

Nu.Q® Cancer White Paper: Lung cancer: hope of a brighter tomorrow
- Share
- Tweet
- Share on Facebook
- Share


Our new White Paper is a deep dive into the science of epigenetics, and its potential to reveal deep insights into the need for lung cancer screening, how lung cancer is currently diagnosed, how it could be diagnosed using Volition’s Nu.Q® Cancer Test.
Related Articles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields